Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Episentum

Episentum?uq=2zON1W4M
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Provider of signal enhancement products designed to develop add-on tools that boost the performance of biosensor instruments. The company's products substantially improve the performance of SPR-based biosensor instruments and expand their breadth of application, enabling clients to develop their biosensor method.

Formerly Known As
Episentec
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Business/Productivity Software
Primary Office
  • Karins väg 5
  • 194 61 Upplands Väsby
  • Sweden

+46 072-007 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Episentum’s full profile, request a free trial.

Episentum Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 27-May-2013 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Episentum Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Almi Invest Corporate Venture Capital Minority 000 0000 000000 0

Episentum Executive Team (1)

Name Title Board
Seat
Contact
Info
Anders Hanning Ph.D Chief Executive Officer, President and Board Member

Episentum Board Members (2)

Name Representing Role Since Contact
Info
Allan Asp Almi Invest Board Member 000 0000
Anders Hanning Ph.D Episentum Chief Executive Officer, President and Board Member 000 0000